Hochschulschrift
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
31 cm
- Umfang
-
ix, 161 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Technische Universität Dresden, Dissertation, 2020
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2019
Ähnliche Objekte (12)
Cellular metabolism as target for cancer therapy
Biomarker based therapies in high risk cancer patients - MACC1 as molecular target
TAp73 upregulates IL-1β in cancer cells : Potential biomarker in lung and breast cancer?
Mitotic centromere-associated kinesin (MCAK) : a potential cancer drug target
Synaptotagmin 13 as a potential target for pancreatic cancer treatment
Phosphorylation of L-plastin as a potential prognostic biomarker in lung cancer
CCL2 chemokine as a potential biomarker for prostate cancer : a pilot study
Functional characterization of transient receptor potential mucolipin-1 channels – potential target for cancer therapy
Bone mineral metabolism in cancer
Evaluation of ITGA2 as a lung cancer marker and potential target for lung cancer therapy
Deregulated microRNAs in biliary tract cancer: functional targets and potential biomarkers
Beyond PD-L1—Identification of Further Potential Therapeutic Targets in Oral Cancer
Cellular metabolism as target for cancer therapy
Biomarker based therapies in high risk cancer patients - MACC1 as molecular target
TAp73 upregulates IL-1β in cancer cells : Potential biomarker in lung and breast cancer?
Mitotic centromere-associated kinesin (MCAK) : a potential cancer drug target
Synaptotagmin 13 as a potential target for pancreatic cancer treatment
Phosphorylation of L-plastin as a potential prognostic biomarker in lung cancer
CCL2 chemokine as a potential biomarker for prostate cancer : a pilot study
Functional characterization of transient receptor potential mucolipin-1 channels – potential target for cancer therapy
Bone mineral metabolism in cancer
Evaluation of ITGA2 as a lung cancer marker and potential target for lung cancer therapy
Deregulated microRNAs in biliary tract cancer: functional targets and potential biomarkers
Beyond PD-L1—Identification of Further Potential Therapeutic Targets in Oral Cancer
Cellular metabolism as target for cancer therapy
Biomarker based therapies in high risk cancer patients - MACC1 as molecular target
TAp73 upregulates IL-1β in cancer cells : Potential biomarker in lung and breast cancer?
Mitotic centromere-associated kinesin (MCAK) : a potential cancer drug target
Synaptotagmin 13 as a potential target for pancreatic cancer treatment
Phosphorylation of L-plastin as a potential prognostic biomarker in lung cancer
CCL2 chemokine as a potential biomarker for prostate cancer : a pilot study
Functional characterization of transient receptor potential mucolipin-1 channels – potential target for cancer therapy
Bone mineral metabolism in cancer
Evaluation of ITGA2 as a lung cancer marker and potential target for lung cancer therapy
Deregulated microRNAs in biliary tract cancer: functional targets and potential biomarkers